Please login to the form below

Not currently logged in
Email:
Password:

Glyconics appoints CEO

Dr Kam Pooni joins the UK diagnostics firm

UK disease management diagnostics firm Glyconics has appointed Dr Kam Pooni as chief executive officer with immediate effect.

Dr Pooni succeeds current chief executive Dr Berwyn Clarke who becomes chairman, while Dr Mike Lewis moves from chairman to non-executive director.

With over 19 years experience in leading life science businesses, Dr Pooni joins Glyconics from Astellas Pharmaceutical Europe where he served as senior director of European commercial operations and effectiveness among other roles.

Dr Clarke said: “Kam is a proven leader, with an impressive combination of vision, passion and experience building and managing pharmaceutical businesses and will play a major role in the development of the business as well as bringing additional experience to the board.

“I look forward to working closely with him at this exciting stage of the company's development.”

11th November 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics